Member Info for Gizzard

Added swim against the tide and accumulate, very few shares around gla.

Robbing people blind, never look a gift horse...

10k there again, acquiring constantly...

Looks like another rns due, code appeared yesterday now one here too.

This guy knows his stuff:

Myles McNulty
@MylesMcNulty
·
49m
#AVCT has successfully generated Affimer-based reagents for detecting #SARSCoV2.

Simply put, this will transform global testing for #COVID19 and be a key tool in removing lockdowns.

Massive news for us shareholders, massive news for the world.

Well done
@avacta
!

Seen it time and time again some people learn the hard way for a few bob... Buy, hold reap the rewards.

As more and more news comes out both gdr and avct will keep on rising, buy hold, reap the rewards...

Missed the boat duster? we don't need funds backed by a giant US pharma, he he lad.

Spot on and incredible RNS, people under played the significance of the tie up in the USA

This will go from strength to strength - let the traders out... bingo.

Whopper...

Could well open up in the mid to high eighties tomorrow, maybe higher... gla

Auction into the close, lockout

Doesn't need to this a global pandemic with billions of tests need. Strong into the close can see it doubling in the near future...

Note the last line.
And there are other AIM-listed coronavirus investment options. For example, antibody test maker Omega Diagnostics (LSE:ODX). The Scottish life sciences firm recently signed a material transfer agreement for London firm Mologic to use its Cambridgeshire factory. This deal will produce 46,000 tests a day. At full capacity that’s 1.15 million tests every month. And Omega already produces bioscience testing for a range of infectious diseases, including malaria, dengue fever and tuberculosis.

Antibody testing is used to identify people who may be immune to the coronavirus who have been infected and have since recovered. This is important in the absence of a vaccine, to allow shuttered economies to start reopening.

But the wrong investment in an unproven and volatile microcap could blow up your portfolio and lose you a lot of money. I’d avoid this one.

Obelix, seen that article they're negative towards omega saying avoid. Usual motley nonsense.

Left it to the derampers...

Starting to hot up here, bid improving very subtly...

Quick let's all follow the advice and sell - I'd rather follow the CEO than some ramblings of an anonymous person.

From the initial RNS that started the rally this reached 39p about 4 weeks ago and we've only doubled since then, so much more to come here given the tech and market cap against an ever growing global market.